Suppression of the growth of the androgen-insensitive R3327 hi rat prostatic carcinoma by combined estrogen and antiprogestin treatment
- 1 November 1991
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 39 (5) , 713-722
- https://doi.org/10.1016/0960-0760(91)90371-b
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- New analogues of mifepristone with more dissociated antiprogesterone activitiesPublished by Elsevier ,2003
- Antitumor activity and mechanism of action of different antiprogestins in experimental breast cancer modelsThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Changes in tumor characteristics during progression of the R3327 HI experimental prostatic carcinomaThe Prostate, 1990
- Immunohistochemical localization of progesterone receptor in benign and malignant human prostateThe Prostate, 1990
- Effect of steroids and antisteroids on human meningioma cells in primary cultureJournal of Steroid Biochemistry, 1989
- Clonal growth of human prostatic epithelial cells is stimulated by fibroblastsThe Prostate, 1989
- Effect of the antiprogesterone RU-38486 on meningioma implanted into nude miceJournal of Neurosurgery, 1987
- Fertility control in women: Results with RU 486 by the end of 1985Journal of Steroid Biochemistry, 1986
- Antiprogestin-receptor complexes: Differences in the interaction of the antiprogestin RU38,486 and the progestin R5020 with the progesterone receptor of human breast cancer cellsBiochemical and Biophysical Research Communications, 1986
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949